FDA Inspection 1100283 — Watson Pharma Private Ltd.

Watson Pharma Private Ltd. — FEI 3008570026

The FDA completed an inspection of Watson Pharma Private Ltd. on Aug 23, 2019 in Navi Mumbai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 23, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Navi Mumbai (India)

Additional Details

Clinical BA/BE

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.